Results 251 to 260 of about 299,715 (311)

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli   +17 more
wiley   +1 more source

Lipid profile shift in high-altitude migrants as a key promoting factor for chronic myocardial injury revealed by lipidomics. [PDF]

open access: yesCell Commun Signal
Deng H   +10 more
europepmc   +1 more source

Longest survivor of pulmonary atresia with ventricular septal defect without surgical intervention

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1499-1507, April 2025.
Sang Zhou   +5 more
wiley   +1 more source

Neuroimaging of acute myocardial injury in stroke: insights into brain lesion locations and network disconnections. [PDF]

open access: yesFront Neurol
Mikulenka P   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy